Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 16, Art. 71 (pp. 766-778)    |    2015       

»

Genetic risk factors of thrombosis and oxidant-antioxidant system in patients with polycythemia vera

Aleksanyan L.R., Ribakova L.P., Kapustin S.I., Zamotina T.B., Bessmeltsev S.S.

Russian Research Institute of Hematology and Transfusiology,
Russian Federal Medico-biological Agency

Brief summary

Prophylaxis of vascular complications is an important part of modern therapy in polycythemia vera (PV). Identification of genetic and acquired risk factors for thrombosis in PV is of great value. In this work, we studied the frequency of several genetic variants associated with thrombosis as well as the peculiarities of oxidant-antioxidant system (OS-AOS) in 100 patients with PV and 200 healthy controls (HC). We found, that mutations FV G1691A and FII G20210A are not associated with increased risk of thrombotic complications in PV. We revealed almost 2-fold decrease in frequency of PAI-1 5G/5G genotype in the group of PV patients with positive history of thrombosis when compared to those free of thrombotic events. This variant of PAI-1 gene could, thus, have protective effect on thrombosis development in PV. We also found, that distribution of genotypes of the β-fibrinogen (factor I), GpIIIa and MTHFR genes as well as their combinations in PV group differed from those in HC. The features of imbalance between oxidant and antioxidant systems were detected in PV patients. This observation could indicate on participation of this acquired factor in pathogenesis of thrombotic and other complications in PV. The growth of oxidation processes was reflected by 40% increase of malondialdehyde content in blood plasma of PV patients (15.4 μmol/l vs. 11.0 μmol/l in HC, (р<0,001). At the same time, the level or/and activity of several components of the antioxidant system were decreased significantly in PV group. In particular, we detected the reduction of ceruloplasmin plasma level (by 30% compared to HC, р<0,01) and non-protein thiol groups content in erythrocytes (by 41% compared to HC, р<0,001) in PV patients. Moreover, the mean ratio of superoxide dismutase to catalase activities was significantly decreased in PV group (р<0,001).


Key words

polycythemia vera, thrombosis, risk factor, inherited thrombophilia, gene, oxidative stress, oxidant-antioxidant system

Reference list

1. Abdylkadirov K.M., Shyvaev V.A., Martinkevich I.S., Shihbabaeva D.I. Sovremennie predstavleniya o diagnostike i lechenii istinnoi policitemii // Vestnik gematologii. – 2015. – T. 11, № 1. – S. 4-46.


2. Gematologiya: Noveishii spravochnik / Pod obsh. red. K.M. Abdylkadirova. – M.: Izd-vo Eksmo; SPb.: Izd-vo Sova, 2004. – 928 s.


3. Gyseva S.A., Bessmelcev S.S., Abdylkadirov K.M., Goncharov Ya.P. Istinnaya policitemiya. – Kiev, SPb.: Logos, 2009. – 405 s.


4. Pop V.P. Istinnaya policitemiya // Gematologiya: nacionalnoe rykovodstvo / pod red. O.A. Rykavicina. – M.: GEOTAR-Media, 2015. – S. 337-345.


5. Menshikova E.B., Zenkov N.K., Lankin V.Z. i soavt. Okislitelnii stress. Patologicheskie sostoyaniya i zabolevaniya. – Novosibirsk: ARTA, 2008. – 284 s.


6. Durmus A., Mentese A., Yilmaz M. et al. The thrombotic events in polycythemia vera patients may be related to increased oxidative stress // Med. Princ. Pract. – 2014. – Vol. 23. – P. 253-258.


7. Samuelsson J., Lindstrom P., Palmblad J. Stimulus-specific defect in oxidative metabolism of polymorphonuclear granulocytes in polycythemia vera // Eur. J. Haematol. – 1988. – Vol. 41. – P. 454-458.


8. Pytilina F.E., Galkina O.V., Eshenko N.D. i soavt. Svobodnoradikalnoe okislenie. SPb: Izd-vo SPb. yniversiteta, 2008. – 161 s.


9. Vladimirov U.A. Svobodnie radikali i antioksidanti // Vestnik Ros. Akad. med. nayk. – 1998, № 7. – S. 43-51.


10. Buico A., Cassino C., Ravera M. et al. Oxidative stress and total antioxidant capacity in human plasma // Redox. Rep. – 2009. – Vol. 14. – P. 125-131.


11. Arytunyan A.V., Dybinina E.E., Zibina N.N. Metodi ocenki svobodnoradikalnogo okisleniya i antioksidantnoi sistemi organizma. SPb. – 2000. – 103 c.


12. Roitman E.V., Davidkin I.L., Kolesnikova I.M. i soavt. Osobennosti reologicheskih svoistv krovi y pacientov s istinnoi policitemiei // Tromboz, gemostaz i reologiya. – 2015. – №3. – S. 8-19.


13. Coucelo M., Caetano G., Sevivas T. et al. JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients // Int. J. Hematol. – 2014. – Vol. 99. – P. 32-40.


14. Barbui T., Finazzi G., Falanga A. Myeloproliferative neoplasms and thrombosis // Blood. – 2013. – Vol. 122. – P. 2176-2184.


15. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells // Nucl. Acid. Res. – 1988. – Vol. 16. – P. 1215-1218.


16. Poort S.R., Rosendaal F.R., Reitsma P.H. et al. A common genetic variation of the 3’ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis // Blood. – 1996. – Vol. 88. – P. 3698-3703.


17. Thomas A., Green F., Kelleher C. et al. Variation in the promoter region of the  fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers // Thromb. Haemost. – 1991. – Vol. 65. – P. 487-490.


18. Gandrille S., Alhenc-Gelas M. and Aiach M. A rapid screening method for the factor V Arg 506Gln mutation. // Blood Coagul. Fibrinolysis. – 1995. – Vol.6. – P. 245-248.


19. Margaglione M., Grandone E., Cappucci G. et al. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing // Thromb. Haemost. – 1997. – Vol. 77. – P. 605-606.


20. Bray P.F., Jin Y., Kickler T. Rapid genotyping of the five major platelet alloantigens by reverse dot-blot hybridization // Blood. – 1994. – Vol. 84. – P. 4361-4367.


21. Arruda V.R., von Zuben P.M., Chiaparini L.C. et al. The mutation Ala677Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis // Thromb. Haemost. – 1997. – Vol.77. – P. 818-821.


22. Andreeva L.I., Kojemyakin L.A., Kishkyn A.A. Modifikaciya metoda opredeleniya perekisi lipidov v teste s tiobarbityrovoi kislotoi // Lab. delo. – 1988. – №11. – S. 41-43.


23. Ravin H., Harvard M. Rapid test for hepatolenticular degeneration // Lancet. – 1956. – Vol. 1. – P. 726-727.


24. Kostuk V.A., Potapovich A.I., Kovaleva J.V. Prostoi i chyvstvitelnii metod opredeleniya aktivnosti syperoksiddismytazi, osnovannii na reakcii okisleniya kvercetina // Vopr. med. himii. – 1990. – T. 36, №2. – S. 88-91.


25. Koroluk M.A., Ivanova L.I., Maiorova I.G., Tokareva V.E. Metod opredeleniya aktivnosti katalazi // Lab. delo. – 1988. – №1. – S. 16-48.


26. Trifa A.P., Cucuianu A., Popp R.A. et al. The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia // Ann. Hematol. – 2014. – Vol. 93. – P. 203-209.


27. Bessmelcev S.S., Fedorova Z.D., Abdylkadirov K.M. Reologicheskie svoistva eritrocitov i sistema gemostaza y bolnih istinnoi policitemiei//Gematol. i transfyziol. – 1989. – №11. – S.29-33.


28. Aleksanyan L.R., Ribakova L.P., Kapystin S.I. Ocenka okislitelno-antiokislitelnoi sistemi y lic s rannim debutom venoznogo tromboza // Materiali VII Vserossiiskoi konferencii «Klinicheskaya gemostaziologiya i gemoreologiya v serdechno-sosydistoi hiryrgii», Moskva. – 2015. – C. 27.